The Bias Toward Action<br />By Rev Shark<br />RealMoney.com Contributor<br />2/12/2009 8:22 AM EST <br /><br />The most important thing in life is not the triumph but the struggle. The essential thing is not to have conquered but to have fought well. <br />-- Baron Pierre de Coubertin<br /><br />As the $800 billion stimulus bill moves toward passage, many doubt we are fighting the economic battle effectively. The market action obviously indicates that investors have little confidence, and the poor way in which the bank bailout program has been announced is only serving to destabilize the market further. <br /><br />I believe there really isn't much that government can do to change the course of the economic cycle. We need to provide a safety net for those at the bottom of the pile, but there is no way we can avoid a good amount of pain for many as the business cycle plays out. <br /><br />There are already way too many market commentators offering economic advice. I'll simply say that I don't believe that all the governmental efforts are going to do much, but the nature of politics is that they will never stop trying to help us, and we will suffer some painful unintended consequences. <br /><br />Our job here is to try to navigate through this market as best we can. It is unquestionably an extremely difficult market, but it is a classic bear market, and it is much more difficult if we try to fight that fact. The surges of hope and the churning action can take a tremendous toll on you if you forget the big picture and the fact that we are still in a major downtrend. <br /><br />If you are a longer-term investor, you should be sitting on the sidelines in cash and staying very patient. If you have a shorter-term perspective then you also need to be patient, but stay watchful for the development of a bear-market bounce. Even the worst bear markets will have some decent tradable bounces and one will develop again sooner or later, no matter how gloomy it is. <br /><br />Unfortunately, conditions for a bounce are not looking so good. The biggest positive we have is the complete dearth of positive news and the very gloomy sentiment. I don't like trying to time turns based on subjective evaluations of the degree of negativity, but you sure aren't going to find a whole lot of optimism out there. <br /><br />The big problem right now is that the indices have been deteriorating technically. We are barely holding onto support levels, and if they crack, we'll need some time to find new support from which another bear-market rally attempt can commence. <br /><br />The most dangerous thing on Wall Street is also the most dangerous thing we are seeing in politics. It is the bias toward action. People who make their living in the stock market are always going to be advising you to do something. They don't want you to just sit there because it renders them useless. It is exactly what we are seeing from politicians these days as well. <br /><br />Sometimes the best way to fight is to simply accept what is and to prepare yourself for the inevitable change in conditions that will eventually occur. That is where we are in the market at this time. Don't waste a lot of emotional and financial capital trying to change the fact that we are in a downcycle. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />Gapping up In reaction to strong earnings/guidance: DFT +21.9% (also upgraded to Outperform at Robert W. Baird and upgraded to Outperform at Wachovia), AIPC +19.7%, BWLD +17.5% (also upgraded to Neutral at MKM Partners), WINN +17.3% (light volume), SNWL +10.8%, CMG +8.5%, ASIA +7.0%, ZGEN +6.2%, O +4.9%, LVS +4.3%, KO +3.2%, RE +3.0%, LIFE +2.7% (light volume), TK +2.5%, TOT +1.5%, GSIC +1.2%... Other news: MGM +2.7% (up in sympathy with LVS), EBS +2.6% (announces that BioThrax receives market authorization in India), STJ +1.6% (Cramer makes positive comments on MadMoney)... Analyst comments: BKC +6.1% (added to Conviction Buy List at Goldman- CNBC, added to Alpha list at Piper Jaffray), CAL +3.8% (upgraded to Buy at BofA/Merrill), CRXL +1.6% (initiated with Buy at Jefferies).<br /><br />Allapoole avanevad:<br /><br />Gapping downIn reaction to disappointing earnings/guidance: GIL -28.4% (also downgraded to Outperform at Raymond James and downgraded to Sector Perform at RBC), TEX -21.4%, PACR -16.0% (light volume; also downgraded to Mkt Perform from Outperform at Morgan Keegan and downgraded to Underperform at Baird), IRE -15.6% (also Moody's downgrades Bank Of Ireland to Aa3/C), WPRT -14.1% (light volume), SQNM -11.2% (also initiated with a Sell at Brean Murray), ELOS -9.7%, EDU -9.7%, BT -9.5% (light volume), MAR -9.3%, STRA -9.2%, ICO -8.8%, NTAP -7.9% (also downgraded to Neutral at MKM Partners), JASO -7.3%, EQIX -7.1%, SCOR -6.8% (light volume; also downgraded to Hold at Collins Stewart), MAS -6.2%, STR -6.0%, AET -6.0%, DEO -5.9%, PTEN -4.2% (light volume), ATVI -3.3%, WSH -1.7% (light volume)... Select financial names showing weakness: AIB -18.9% (provides capital update; confirms that it has been in further negotiations with the Irish Government), LNC -5.3%, BAC -4.8%, ING -4.1%, RF -4.1%, BCS -3.8%, WFC -3.4%, JPM -1.8%, GS -1.5%, UBS -1.4%... Select education related names trading lower following disappointing STRA and EDU results: CECO -6.7%, APOL -3.5%... Select metals/mining names showing weakness: AAUK -6.5%, BBL -4.9%, BHP -4.8%, AU -4.2%, GOLD -3.2%, RIO -3.0%, HMY -2.7%, MT -2.4%, GFI -1.7%... Select oil/gas related names trading modestly lower with weakness in crude: REP -3.8%, PBR -2.5%, CVX -1.6%, E -1.0%... Other news: GNK -4.1% (details limited exposure to Samsun Logix), BMRN -4.1% (announces results of first interim efficacy analysis for Riquent Phase 3 trial; says "continuation of trial is futile"), UNH -3.6% (down in sympathy with AET), SNY -1.6% and AZN -1.3% (still checking for anything specific)... Analyst comments: KSS -3.8% (downgraded to Sell from Neutral at Goldman- CNBC), RTN -2.1% (downgraded to Market Perform at Bernstein), NYX -1.7% (downgraded to Hold at Citigroup).